Metastatic Uveal Melanoma Active Not Recruiting Phase 1 Trials for Ipilimumab (DB06186)

Also known as: Metastatic Malignant Uveal Melanoma / Metastatic Uveal Melanoma (UM) / Uveal Melanoma, Metastatic / Melanoma, Uveal Metastatic

IndicationStatusPhase
DBCOND0051900 (Metastatic Uveal Melanoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03068624Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal MelanomaTreatment